Nov 5, 7:40 AM ET
Lantheus reported third quarter 2026 revenue of $389.9 million, up 1.5%, while GAAP diluted earnings per share fell to $0.33 from $0.41 and adjusted diluted EPS rose to $1.68 from $1.27. The company suspended its full year 2026 guidance because of its pending all-cash merger with Curium, which values Lantheus at up to $8.0 billion including contingent value rights.
- Worldwide revenue was $389.9 million, up 1.5% from $384.0 million a year earlier; GAAP net income fell 19.4% to $22.4 million.
- Operating income decreased 26.2% to $32.2 million, including a $31.0 million impairment of intangible assets.
- Full year 2026 financial guidance was suspended in connection with the pending merger with Curium.
- Curium would pay $102.50 per share in cash plus up to $12.00 per share in contingent value rights, a total of up to $114.50 per share.
Read the filing on SEC.gov ↗
Oct 22, 7:30 AM ET
Lantheus and Curium's parent each received a Second Request from the FTC on October 21, 2026, in its review of the August 3, 2026 merger agreement. The request extends the HSR Act waiting period until 30 days after substantial compliance, so closing is pending longer, though the companies still expect completion in the first half of 2027.
- FTC issued Second Requests to Lantheus and Parent on October 21, 2026
- Waiting period extends until 30 days after both parties substantially comply with the requests
- Companies still expect the merger to close in the first half of 2027
Read the filing on SEC.gov ↗
Aug 6, 7:45 AM ET
Lantheus reported second quarter 2026 revenue of $388.2 million, up 2.7% from a year earlier, while GAAP diluted earnings per share were $1.11 versus $1.12 and adjusted diluted earnings per share were $1.55 versus $1.57. The company suspended its full year 2026 guidance and will not hold a conference call, citing the pending merger with Curium announced August 3, 2026, under which shareholders would receive $102.50 per share in cash plus contingent value rights worth up to $12.00 per share.
- Worldwide revenue of $388.2 million, up 2.7%; PYLARIFY sales of $240.4 million, down 4.1%
- GAAP net income of $75.0 million, down 4.7%; adjusted net income of $104.9 million, down 5.1%
- Full year 2026 guidance suspended in connection with the pending transaction
- Merger consideration of $102.50 per share in cash plus CVRs of up to $12.00 per share; total transaction value of up to approximately $8.0 billion
Read the filing on SEC.gov ↗
Aug 3, 9:00 PM ET
Lantheus Holdings entered a merger agreement under which Curium US Holdings would acquire the company, with Lantheus surviving as a wholly owned subsidiary of Curium's parent. Shareholders would receive $102.50 per share in cash plus one contingent value right worth up to $12.00 per share upon certain commercial milestones, so the deal would end their ownership of the stock and its Nasdaq listing.
- Cash consideration of $102.50 per share plus one CVR paying up to $12.00 in cash on specified commercial milestones
- Closing requires stockholder approval, expiration or termination of the HSR waiting period, and other customary conditions; no financing condition
- Either party may terminate if the merger is not completed by May 2, 2027, subject to extensions
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
